1/4 Here we go! Chess eats your 🧠 gray matter!
"Grey matter volume and cortical thickness were reduced in chess players compared with those of control men in the occipitotemporal junction and precunei." #Chess#chesspunks#NorwayChess
2/4 Chess is a silent "killer" of 🧠 cortex locally.
💡Who holds the record for the thinnest 🧠 cortex among chess players in history? Will collective chess 🧠 solve this mystery despite the thinning? Retweet! 🔁 #Chess#chesspunks#brain#neuroscience#NorwayChess
3/4 🧩 Stay tuned for more revelations from a treasure trove of almost 1000 scientific papers exploring the mental and other challenges of chess players. As a chess player myself, I hope for 1 or 2 papers highlighting the benefits of the game. #Chess#chesspunks#NorwayChess 🔁
1/ "Fits at Chess" might seem like a punchline, but it's a real health concern 🧠. I've been exploring research papers on the negative effects of #Chess on well-being, societies, and ecosystems, and found the first report of chess triggering #epilepsy from 1965. #NorwayChess
2/ These cases fall into a category of reflex #epilepsy - seizures are activated by specific, identifiable triggers. Such triggers can be external (flashing lights, hot water 🚿), internal (emotions, thought 💭), or a mix of both. #chess#NorwayChess#neuroscience#brain
3/ Among reflex #epilepsies, the most common are those triggered by visual stimuli or light changes (1 in 4,000). Much rarer triggers include eating 🍎, music 🎵(1:10 M), writing ✍️, orgasm 💋 and even lying. #Chess, other #boardgames, and #cards can also trigger seizures.
Course objectives:
🚀 Define Large Language Models (LLMs)
🚀 Describe LLM Use Cases
🚀 Explain Prompt Tuning
🚀 Describe Google’s Gen AI Development tools #AI#ArtificialIntelligence#courses 2/3
It only takes an hour to get the fundamental concepts! 🕐. Afterward, check out an insightful presentation from OpenAI, a competitor of Google, on the training and application of LLMs. #AI#ArtificialIntelligence#ChatGPT 3/3 🧠🚀
💊 Older adults make up 56% of the global cancer population, yet they're just 40% of participants in new cancer therapy trials. The underrepresentation of this key demographic in clinical trials is a major concern. #clinicaltrials#healthcare#aging
💊Trials biased towards younger patients without comorbidities and multiple prescription drugs yield cleaner datasets but may not provide sufficient evidence on drug safety and efficacy for older populations. 2/3 #ClinicalTrials#aging#healthcare
💊 US and UK regulators recognize the problem and have issued guidelines to address it recently. While guidelines and incentives can make a difference, legislation may be necessary to fully tackle the problem in the end. ⚖️ 3/3 #ClinicalTrials#aging#healthcare#FDA